Metraipolis › archive › dc_6806ceaf322d

Prognostic Significance of Ultralow (UL) Prostate-Specific Antigen (PSA) in Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): A Single… — Europe PMC PMID:41470112

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41470112
DOI
10.3390/medicina61122110
License (as archived)
solo-consultazione
Archived
2026-11-08T04:56:49.306Z
SHA-256 of the archived text
8348dd23b2f72eb03fbcc6d7bd230481103a4e71daa4a768ebeb40ee74e226d7
Stable URL of this page
https://metraipolis.com/documento/dc_6806ceaf322d

How to cite

Prognostic Significance of Ultralow (UL) Prostate-Specific Antigen (PSA) in Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): A Single… — Europe PMC PMID:41470112 — Europe PMC (en), https://europepmc.org/article/MED/41470112 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6806ceaf322d (Metraipolis archive dc_6806ceaf322d, sha256 8348dd23b2f72eb03fbcc6d7bd230481103a4e71daa4a768ebeb40ee74e226d7)
BibTeX
@misc{dc6806ceaf322d,
  title = {Prognostic Significance of Ultralow (UL) Prostate-Specific Antigen (PSA) in Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): A Single… — Europe PMC PMID:41470112},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41470112},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6806ceaf322d; sha256 8348dd23b2f72eb03fbcc6d7bd230481103a4e71daa4a768ebeb40ee74e226d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41470112. Agents can read the archived copy with the MCP tool read_document.